Skip to content
10-Q

Quarterly Report

PLIANT THERAPEUTICS, INC. PLRX

0001746473-25-000175

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 1, 2025 61.45M sh
Shares Diluted Q3 2025 · Sep 30, 2025 61.41M sh
Shares Diluted Q3 2025 · Sep 30, 2025 61.34M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.73M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.43M sh
Capex Q3 2025 · Sep 30, 2025 $374K
Capex Q3 2025 · Sep 30, 2024 $3.64M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$110.55M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$107.84M
Long Term Debt Q3 2025 · Sep 30, 2025 $30.44M
Long Term Debt Q3 2025 · Dec 31, 2024 $30.21M
Short Term Investments Q3 2025 · Sep 30, 2025 $148.07M
Short Term Investments Q3 2025 · Dec 31, 2024 $284.54M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $93.73M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $71.19M
Stockholders Equity Q3 2025 · Sep 30, 2025 $200.31M
Stockholders Equity Q3 2025 · Jun 30, 2025 $220.08M
Stockholders Equity Q3 2025 · Mar 31, 2025 $257.16M
Stockholders Equity Q3 2025 · Dec 31, 2024 $304.08M
Stockholders Equity Q3 2025 · Sep 30, 2024 $345.82M
Stockholders Equity Q3 2025 · Jun 30, 2024 $392.68M
Stockholders Equity Q3 2025 · Mar 31, 2024 $437.33M
Stockholders Equity Q3 2025 · Dec 31, 2023 $473.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $17.62M
Current Liabilities Q3 2025 · Dec 31, 2024 $33.22M
Total Liabilities Q3 2025 · Sep 30, 2025 $76.29M
Total Liabilities Q3 2025 · Dec 31, 2024 $92.87M
Current Assets Q3 2025 · Sep 30, 2025 $245.59M
Current Assets Q3 2025 · Dec 31, 2024 $362.26M
Total Assets Q3 2025 · Sep 30, 2025 $276.6M
Total Assets Q3 2025 · Dec 31, 2024 $396.95M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.43
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.05
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.95
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.66
Eps Basic Q3 2025 · Sep 30, 2025 −$0.43
Eps Basic Q3 2025 · Sep 30, 2025 −$2.05
Eps Basic Q3 2025 · Sep 30, 2024 −$0.95
Eps Basic Q3 2025 · Sep 30, 2024 −$2.66
Sga Expense Q3 2025 · Sep 30, 2025 $10.33M
Sga Expense Q3 2025 · Sep 30, 2025 $39.22M
Sga Expense Q3 2025 · Sep 30, 2024 $14.26M
Sga Expense Q3 2025 · Sep 30, 2024 $44.53M
Rd Expense Q3 2025 · Sep 30, 2025 $17.94M
Rd Expense Q3 2025 · Sep 30, 2025 $93.57M
Rd Expense Q3 2025 · Sep 30, 2024 $47.75M
Rd Expense Q3 2025 · Sep 30, 2024 $130.52M
Net Income Q3 2025 · Sep 30, 2025 −$26.3M
Net Income Q3 2025 · Sep 30, 2025 −$125.77M
Net Income Q3 2025 · Jun 30, 2025 −$43.3M
Net Income Q3 2025 · Mar 31, 2025 −$56.17M
Net Income Q3 2025 · Sep 30, 2024 −$57.76M
Net Income Q3 2025 · Sep 30, 2024 −$160.57M
Net Income Q3 2025 · Jun 30, 2024 −$55.85M
Net Income Q3 2025 · Mar 31, 2024 −$46.96M
Operating Income Q3 2025 · Sep 30, 2025 −$28.27M
Operating Income Q3 2025 · Sep 30, 2025 −$132.8M
Operating Income Q3 2025 · Sep 30, 2024 −$62.01M
Operating Income Q3 2025 · Sep 30, 2024 −$175.05M